Related Experiment Videos
Multidrug-resistant tuberculosis in bone marrow transplant recipient
J Altclas1, A Lescano, C Salgueira
1Department of Infectious Diseases, Sanatorio Mitre, Buenos Aires, Argentina. jaltclas@intramed.net.ar
Summary
Multidrug-resistant tuberculosis (TB) is a growing global health threat. This case study details successful treatment of multidrug-resistant TB in a bone marrow transplant recipient using second-line therapies.
Area of Science:
- Infectious Diseases
- Hematology
- Transplantation Medicine
Background:
- Multidrug-resistant tuberculosis (TB) poses a significant global health challenge.
- TB in transplant recipients is rare, with limited documented cases, particularly in lung and heart transplants.
Observation:
- A case of multidrug-resistant TB was identified in an allogeneic bone marrow transplant recipient.
- This patient population presents unique challenges for managing infectious diseases due to immunosuppression.
Findings:
- The patient received second-line anti-TB therapy.
- A good clinical response to the second-line treatment was observed.
Implications:
- This case highlights the possibility of successful treatment for multidrug-resistant TB in immunocompromised patients.
- Further research into optimal therapeutic strategies for multidrug-resistant TB in transplant recipients is warranted.